July 16, 2026 · Form 4 insider transaction
BOBULSKY SUSAN sold 5,000 shares of Adaptive Biotechnologies Corporation at $23.00 per share, a transaction worth $115.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025.